Inventor

STUBENRAUCH KAY-GUNNAR

DE36 patents

⚠️ This page may combine multiple inventors who share the name “STUBENRAUCH KAY-GUNNAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STUBENRAUCH KAY-GUNNAR

HOFFMANN LA ROCHE

Anti-P-selectin antibodies

Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies

Method for producing chimeric polypeptides

Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples

Nucleic acid molecules encoding anti-P-selectin antibodies

Method for the detection of a binding partner of a multispecific binder

Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples

Antigen binding receptors specific for mutated Fc domains

Method for the detection of a binding partner of a multispecific binder

Method for the detection of free binding partner of a multispecific binder

Method for determining the amount of a therapeutic antibody in the brain

Method for the determination of anti-drug antibodies against an effector function suppressed human or humanized drug antibody

Antigen binding receptors specific for mutated Fc domains

Protease-activated T cell bispecific molecules

Anti-variant Fc-region antibodies and method of use

Anti-variant Fc-region antibodies and method of use

Immunoassay for the determination of Fc-region modified antibodies

Anti-drug antibody assay

Anti-idiotype antibody against an antibody against the amyloid β peptide

Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies

Anti-human IgG1 antibody

Method for determining anti-drug antibodies in a minipig sample

Specific detection of rat antibodies in mouse serum

Method for the detection of a multispecific binder

STUBENRAUCH KAY-GUNNAR

Distinguishing assay

Distinguishing assay

Conjugate and its use as a standard in an immunoassay

ROCHE GLYCART AG

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

GRAUS YVO

Nucleic acid molecules encoding anti-P-selectin antibodies

Anti-P-selectin antibodies

ESSIG ULRICH

Anti-idiotype antibody against an antibody against the amyloid β peptide

Non-cross-reactive anti IgG antibodies

BAEHNER MONIKA

Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies

ROCHE PALO ALTO LLC

Antibodies against IL-13 receptor alpha1 and uses thereof

HOFFMANN & MDASH LA ROCHE INC

Detection of a therapeutic antibody in an experimental animal